Fate Therapeutics (FATE) Other financing activities (2015 - 2024)

Fate Therapeutics (FATE) has 9 years of Other financing activities data on file, last reported at $18.1 million in Q4 2024.

• Quarterly Other financing activities changed N/A year-over-year to $18.1 million in Q4 2024, while the trailing twelve-month figure through Sep 2025 was $18.1 million (up 830.72% YoY) and the FY2024 annual result came in at $20.0 million, changed N/A from the prior year.
• Other financing activities rose to $18.1 million in Q4 2024, from -$72.6 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $75.2 million in Q1 2024 to a low of -$72.6 million in Q3 2024.
• A 5-year average of $1.6 million and a median of $1.5 million in 2022 frame the typical range for Other financing activities.
• Annual changes were most pronounced in 2020 — Other financing activities soared 7167.44% — and 2024, when it sank 27292.83%.
• Tracing FATE's Other financing activities over 5 years: stood at -$49.5 million in 2020, then soared by 65.13% to -$17.3 million in 2021, then jumped by 108.79% to $1.5 million in 2022, then plunged by 117.47% to -$265000.0 in 2023, then soared by 6913.58% to $18.1 million in 2024.
• The last three Other financing activities figures came in at $18.1 million (Q4 2024), -$72.6 million (Q3 2024), and -$662000.0 (Q2 2024), per Business Quant data.